Juan Macı́as

8.0k total citations
223 papers, 4.5k citations indexed

About

Juan Macı́as is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Juan Macı́as has authored 223 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Epidemiology, 156 papers in Hepatology and 64 papers in Infectious Diseases. Recurrent topics in Juan Macı́as's work include Hepatitis C virus research (145 papers), Liver Disease Diagnosis and Treatment (108 papers) and Hepatitis B Virus Studies (58 papers). Juan Macı́as is often cited by papers focused on Hepatitis C virus research (145 papers), Liver Disease Diagnosis and Treatment (108 papers) and Hepatitis B Virus Studies (58 papers). Juan Macı́as collaborates with scholars based in Spain, United States and United Kingdom. Juan Macı́as's co-authors include Juan A. Pineda, Antonio Rivero, José Antonio López Mira, Nicolás Merchante, José Ángel García-García, Ángela Camacho, Jesús Gómez‐Mateos, Karin Neukam, Dolores Merino and Mercedes González‐Serrano and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Juan Macı́as

212 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Macı́as Spain	38	3.1k	3.1k	1.3k	530	489	223	4.5k
Andrzej Horban Poland	34	2.2k 0.7×	2.4k 0.8×	2.1k 1.6×	1.2k 2.4×	504 1.0×	183	4.6k
Javier García‐Samaniego Spain	34	3.5k 1.1×	3.3k 1.1×	1.2k 0.9×	279 0.5×	283 0.6×	163	4.3k
Giuseppe Pastore Italy	30	2.6k 0.8×	2.8k 0.9×	945 0.7×	422 0.8×	329 0.7×	111	3.9k
Juan González‐García Spain	27	1.7k 0.5×	1.9k 0.6×	1.7k 1.3×	790 1.5×	660 1.3×	165	3.5k
Karine Lacombe France	34	2.1k 0.7×	2.5k 0.8×	1.3k 1.0×	243 0.5×	235 0.5×	219	3.7k
Cristina Tural Spain	33	1.9k 0.6×	2.0k 0.7×	2.0k 1.5×	1.2k 2.3×	514 1.1×	114	3.8k
Andrew H. Talal United States	35	2.9k 0.9×	2.6k 0.9×	1.2k 0.9×	1.3k 2.4×	183 0.4×	141	5.1k
George J. Nemo United States	30	1.3k 0.4×	1.9k 0.6×	1.2k 1.0×	602 1.1×	325 0.7×	50	4.7k
Pablo Labarga Spain	36	2.1k 0.7×	2.2k 0.7×	2.0k 1.5×	849 1.6×	617 1.3×	137	3.8k
Massimo Puoti Italy	47	7.0k 2.3×	6.6k 2.2×	2.5k 1.9×	651 1.2×	571 1.2×	263	9.1k

Countries citing papers authored by Juan Macı́as

Since Specialization

Citations

This map shows the geographic impact of Juan Macı́as's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Macı́as with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Macı́as more than expected).

Fields of papers citing papers by Juan Macı́as

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Macı́as. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Macı́as. The network helps show where Juan Macı́as may publish in the future.

Co-authorship network of co-authors of Juan Macı́as

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Macı́as. A scholar is included among the top collaborators of Juan Macı́as based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Macı́as. Juan Macı́as is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corma‐Gómez, Anaïs, Marı́a José Galindo, Ángela Camacho, et al.. (2025). FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure. Open Forum Infectious Diseases. 12(4). ofae628–ofae628.

González‐Serna, Alejandro, Anaïs Corma‐Gómez, Mercedes Cano, et al.. (2025). Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response. The Journal of Infectious Diseases. 231(5). e846–e852.

Izquierdo, Rebeca, Alejandro Vallejo, Inés Suárez‐García, et al.. (2025). Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 274–282.

Montes, Marisa, Carmen Busca, Núria Espinosa, et al.. (2024). Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile. Open Forum Infectious Diseases. 11(4). ofae112–ofae112. 4 indexed citations

Macı́as, Juan, Mario Frías, Juan A. Pineda, et al.. (2024). Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV. Alimentary Pharmacology & Therapeutics. 61(3). 550–557.

Martín‐Escolano, Rubén, Javier Crespo, Pablo Ryan, et al.. (2023). Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk. Immunity & Ageing. 20(1). 62–62. 4 indexed citations

Fernández‐Fuertes, Marta, Juan Macı́as, Anaïs Corma‐Gómez, et al.. (2023). Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(5). 251–256.

Fernández‐Fuertes, Marta, Juan Macı́as, Anaïs Corma‐Gómez, et al.. (2023). Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain. Enfermedades Infecciosas y Microbiología Clínica. 42(5). 251–256. 1 indexed citations

Corma‐Gómez, Anaïs, et al.. (2023). Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide. Open Forum Infectious Diseases. 10(11). ofad532–ofad532.

10.

Fernández‐Fuertes, Marta, Anaïs Corma‐Gómez, Eva Torres, et al.. (2021). Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic. Transboundary and Emerging Diseases. 69(4). e267–e275. 5 indexed citations

11.

Corma‐Gómez, Anaïs, Juan Macı́as, Antonio Rivero, et al.. (2021). A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure. Diagnostics. 11(8). 1501–1501. 1 indexed citations

12.

Macı́as, Juan, Ramón Morillo‐Verdugo, J.J. Pérez-Venegas, et al.. (2021). Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy. PLoS ONE. 16(4). e0249036–e0249036. 5 indexed citations

13.

Rivero‐Juárez, Antonio, David Guijo-Rubio, Francisco Téllez, et al.. (2020). Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals. PLoS ONE. 15(1). e0227188–e0227188. 4 indexed citations

14.

González‐Serna, Alejandro, Juan Macı́as, Rosario Palacios, et al.. (2020). Incidence of recently acquired hepatitis C virus infection among HIV‐infected patients in southern Spain. HIV Medicine. 22(5). 379–386. 10 indexed citations

15.

Macı́as, Juan, Luís Morano, Francisco Téllez, et al.. (2019). Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. Journal of Hepatology. 71(1). 45–51. 44 indexed citations

16.

Macı́as, Juan, Francisco Téllez, Antonio Rivero‐Juárez, et al.. (2018). Early emergence of opportunistic infections after starting direct‐acting antiviral drugs in HIV/HCV‐coinfected patients. Journal of Viral Hepatitis. 26(1). 48–54. 4 indexed citations

17.

Real, Luís Miguel, Juan Macı́as, Ana Belén Pérez, et al.. (2018). Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Scientific Reports. 8(1). 14905–14905. 3 indexed citations

18.

McCombe, Geoff, Davina Swan, Gordana Avramovic, et al.. (2018). Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care. JMIR Research Protocols. 7(6). e149–e149. 8 indexed citations

19.

Macı́as, Juan, Rafael Granados, Francisco Téllez, et al.. (2018). Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection. Journal of Viral Hepatitis. 26(1). 16–24. 10 indexed citations

20.

Merchante, Nicolás, Teresa Aldámiz‐Echevarría, Mónica García–Álvarez, et al.. (2017). Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients. Journal of Viral Hepatitis. 25(2). 180–186. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact